Identification of Potent and Selective Small-Molecule Inhibitors of Caspase-3 through the Use of Extended Tethering and Structure-Based Drug Design

التفاصيل البيبلوغرافية
العنوان: Identification of Potent and Selective Small-Molecule Inhibitors of Caspase-3 through the Use of Extended Tethering and Structure-Based Drug Design
المؤلفون: Choong, I. C., Lew, W., Lee, D., Pham, P., Burdett, M. T., Lam, J. W., Wiesmann, C., Luong, T. N., Fahr, B., DeLano, W. L., McDowell, R. S., Allen, D. A., Erlanson, D. A., Gordon, E. M., O'Brien, T.
المصدر: Journal of Medicinal Chemistry; November 2002, Vol. 45 Issue: 23 p5005-5022, 18p
مستخلص: The design, synthesis, and in vitro activities of a series of potent and selective small-molecule inhibitors of caspase-3 are described. From extended tethering, a salicylic acid fragment was identified as having binding affinity for the S4 pocket of caspase-3. X-ray crystallography and molecular modeling of the initial tethering hit resulted in the synthesis of 4, which reversibly inhibited caspase-3 with a Ki = 40 nM. Further optimization led to the identification of a series of potent and selective inhibitors with Ki values in the 20−50 nM range. One of the most potent compounds in this series, 66b, inhibited caspase-3 with a Ki = 20 nM and selectivity of 8−500-fold for caspase-3 vs a panel of seven caspases (1, 2, and 4−8). A high-resolution X-ray cocrystal structure of 4 and 66b supports the predicted binding modes of our compounds with caspase-3.
قاعدة البيانات: Supplemental Index
ResultId 1
Header edo
Supplemental Index
ejs3894454
817
6
Periodical
serialPeriodical
816.503601074219
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs3894454&custid=s6537998&authtype=sso
FullText Array ( [Availability] => 0 )
Items Array ( [Name] => Title [Label] => Title [Group] => Ti [Data] => Identification of Potent and Selective Small-Molecule Inhibitors of Caspase-3 through the Use of Extended Tethering and Structure-Based Drug Design )
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Choong%2C+I%2E+C%2E%22">Choong, I. C.</searchLink><br /><searchLink fieldCode="AR" term="%22Lew%2C+W%2E%22">Lew, W.</searchLink><br /><searchLink fieldCode="AR" term="%22Lee%2C+D%2E%22">Lee, D.</searchLink><br /><searchLink fieldCode="AR" term="%22Pham%2C+P%2E%22">Pham, P.</searchLink><br /><searchLink fieldCode="AR" term="%22Burdett%2C+M%2E+T%2E%22">Burdett, M. T.</searchLink><br /><searchLink fieldCode="AR" term="%22Lam%2C+J%2E+W%2E%22">Lam, J. W.</searchLink><br /><searchLink fieldCode="AR" term="%22Wiesmann%2C+C%2E%22">Wiesmann, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Luong%2C+T%2E+N%2E%22">Luong, T. N.</searchLink><br /><searchLink fieldCode="AR" term="%22Fahr%2C+B%2E%22">Fahr, B.</searchLink><br /><searchLink fieldCode="AR" term="%22DeLano%2C+W%2E+L%2E%22">DeLano, W. L.</searchLink><br /><searchLink fieldCode="AR" term="%22McDowell%2C+R%2E+S%2E%22">McDowell, R. S.</searchLink><br /><searchLink fieldCode="AR" term="%22Allen%2C+D%2E+A%2E%22">Allen, D. A.</searchLink><br /><searchLink fieldCode="AR" term="%22Erlanson%2C+D%2E+A%2E%22">Erlanson, D. A.</searchLink><br /><searchLink fieldCode="AR" term="%22Gordon%2C+E%2E+M%2E%22">Gordon, E. M.</searchLink><br /><searchLink fieldCode="AR" term="%22O'Brien%2C+T%2E%22">O'Brien, T.</searchLink> )
Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Journal of Medicinal Chemistry; November 2002, Vol. 45 Issue: 23 p5005-5022, 18p )
Array ( [Name] => Abstract [Label] => Abstract [Group] => Ab [Data] => The design, synthesis, and in vitro activities of a series of potent and selective small-molecule inhibitors of caspase-3 are described. From extended tethering, a salicylic acid fragment was identified as having binding affinity for the S<INF>4</INF> pocket of caspase-3. X-ray crystallography and molecular modeling of the initial tethering hit resulted in the synthesis of <BO>4</BO>, which reversibly inhibited caspase-3 with a K<INF>i</INF> = 40 nM. Further optimization led to the identification of a series of potent and selective inhibitors with K<INF>i</INF> values in the 20−50 nM range. One of the most potent compounds in this series, <BO>66b</BO>, inhibited caspase-3 with a K<INF>i</INF> = 20 nM and selectivity of 8−500-fold for caspase-3 vs a panel of seven caspases (1, 2, and 4−8). A high-resolution X-ray cocrystal structure of <BO>4 </BO>and <BO>66b</BO> supports the predicted binding modes of our compounds with caspase-3. )
RecordInfo Array ( [BibEntity] => Array ( [Identifiers] => Array ( [0] => Array ( [Type] => doi [Value] => 10.1021/jm020230j ) ) [Languages] => Array ( [0] => Array ( [Code] => eng [Text] => English ) ) [PhysicalDescription] => Array ( [Pagination] => Array ( [PageCount] => 18 [StartPage] => 5005 ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Identification of Potent and Selective Small-Molecule Inhibitors of Caspase-3 through the Use of Extended Tethering and Structure-Based Drug Design [Type] => main ) ) ) [BibRelationships] => Array ( [HasContributorRelationships] => Array ( [0] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Choong, I. C. ) ) ) [1] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Lew, W. ) ) ) [2] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Lee, D. ) ) ) [3] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Pham, P. ) ) ) [4] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Burdett, M. T. ) ) ) [5] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Lam, J. W. ) ) ) [6] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Wiesmann, C. ) ) ) [7] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Luong, T. N. ) ) ) [8] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Fahr, B. ) ) ) [9] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => DeLano, W. L. ) ) ) [10] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => McDowell, R. S. ) ) ) [11] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Allen, D. A. ) ) ) [12] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Erlanson, D. A. ) ) ) [13] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => Gordon, E. M. ) ) ) [14] => Array ( [PersonEntity] => Array ( [Name] => Array ( [NameFull] => O'Brien, T. ) ) ) ) [IsPartOfRelationships] => Array ( [0] => Array ( [BibEntity] => Array ( [Dates] => Array ( [0] => Array ( [D] => 01 [M] => 11 [Text] => November 2002 [Type] => published [Y] => 2002 ) ) [Identifiers] => Array ( [0] => Array ( [Type] => issn-print [Value] => 00222623 ) [1] => Array ( [Type] => issn-print [Value] => 15204804 ) ) [Numbering] => Array ( [0] => Array ( [Type] => volume [Value] => 45 ) [1] => Array ( [Type] => issue [Value] => 23 ) ) [Titles] => Array ( [0] => Array ( [TitleFull] => Journal of Medicinal Chemistry [Type] => main ) ) ) ) ) ) )
IllustrationInfo